Rongxue Peng

712 total citations
28 papers, 425 citations indexed

About

Rongxue Peng is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Rongxue Peng has authored 28 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Rongxue Peng's work include Cancer Genomics and Diagnostics (10 papers), CRISPR and Genetic Engineering (9 papers) and RNA and protein synthesis mechanisms (5 papers). Rongxue Peng is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), CRISPR and Genetic Engineering (9 papers) and RNA and protein synthesis mechanisms (5 papers). Rongxue Peng collaborates with scholars based in China and Australia. Rongxue Peng's co-authors include Jinming Li, Guigao Lin, Rui Zhang, Li Zhou, Yanxi Han, Kuo Zhang, Xin Yang, Peng Gao, Jiehong Xie and Rui Zhang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Clinical Chemistry.

In The Last Decade

Rongxue Peng

26 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongxue Peng China 9 313 93 62 56 41 28 425
Jinzhi Duan China 9 361 1.2× 55 0.6× 100 1.6× 76 1.4× 22 0.5× 13 532
Wensheng Zhang China 11 465 1.5× 48 0.5× 45 0.7× 75 1.3× 21 0.5× 19 572
Cynthia M. Megyola United States 8 295 0.9× 64 0.7× 102 1.6× 30 0.5× 24 0.6× 10 414
Hannah Greenfeld United States 6 283 0.9× 81 0.9× 84 1.4× 30 0.5× 34 0.8× 6 479
Justin Low United States 10 353 1.1× 42 0.5× 41 0.7× 21 0.4× 16 0.4× 30 522
R Seipelt United States 14 554 1.8× 37 0.4× 44 0.7× 34 0.6× 41 1.0× 32 799
Kieran O’Neill Canada 14 408 1.3× 74 0.8× 25 0.4× 68 1.2× 33 0.8× 28 576
Samantha Maragh United States 13 513 1.6× 108 1.2× 45 0.7× 106 1.9× 11 0.3× 19 586
Xavier Gaume France 9 496 1.6× 55 0.6× 49 0.8× 40 0.7× 32 0.8× 10 566

Countries citing papers authored by Rongxue Peng

Since Specialization
Citations

This map shows the geographic impact of Rongxue Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongxue Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongxue Peng more than expected).

Fields of papers citing papers by Rongxue Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongxue Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongxue Peng. The network helps show where Rongxue Peng may publish in the future.

Co-authorship network of co-authors of Rongxue Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Rongxue Peng. A scholar is included among the top collaborators of Rongxue Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongxue Peng. Rongxue Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Duo, et al.. (2024). Enhancing the quality of panel-based tumor mutation burden assessment: a comprehensive study of real-world and in-silico outcomes. npj Precision Oncology. 8(1). 18–18. 2 indexed citations
2.
Zhou, Gang, Huijuan Wang, Tingli Sun, et al.. (2024). Exploring the gut microbiota and metabolome of Lateolabrax japonicus: A multi-omics approach. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 54. 101408–101408.
3.
Zhang, Kuo, Guigao Lin, Yanxi Han, Rongxue Peng, & Jinming Li. (2023). Analysis of Clinical Laboratory Detecting Challenging Variants from Exome Sequencing Using Simulated Patient–Parent Trio Sample. Journal of Molecular Diagnostics. 25(6). 378–387.
4.
Lin, Guigao, Kuo Zhang, Yanxi Han, et al.. (2022). Reprogramming of Human B Cells from Secreting IgG to IgM by Genome Editing. The CRISPR Journal. 5(5). 717–725. 1 indexed citations
5.
Peng, Rongxue, Guigao Lin, Lin Li, & Jinming Li. (2022). Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology. Frontiers in Oncology. 12. 845636–845636. 2 indexed citations
6.
Peng, Rongxue, Rui Zhang, & Jinming Li. (2022). Continual Improvement of the Reliability of Next-Generation Sequencing-Based ctDNA Analysis: A Long-Term Comparison of ctDNA Detection in China. Clinical Chemistry. 68(7). 940–952. 3 indexed citations
7.
Zhang, Kuo, Guigao Lin, Dongsheng Han, et al.. (2022). Adaptation of ACMG-ClinGen Technical Standards for Copy Number Variant Interpretation Concordance. Frontiers in Genetics. 13. 829728–829728. 7 indexed citations
8.
Li, Dandan, et al.. (2021). Delivery of microRNA-21-sponge and pre-microRNA-122 by MS2 virus-like particles to therapeutically target hepatocellular carcinoma cells. Experimental Biology and Medicine. 246(23). 2463–2472. 15 indexed citations
9.
Zhou, Li, Rui Li, Runling Zhang, et al.. (2020). Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing. Journal of Clinical Laboratory Analysis. 34(7). e23256–e23256. 2 indexed citations
10.
Wang, Zhe, H. J. Yang, Yanxi Han, et al.. (2020). External Quality Assessment for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Clinical Laboratories. Journal of Molecular Diagnostics. 23(1). 19–28. 22 indexed citations
11.
Li, Dandan, Jiawei Zhang, Rui Zhang, et al.. (2020). Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis. Chinese Medical Journal. 134(7). 848–850. 7 indexed citations
12.
Peng, Rongxue, Rui Zhang, Martin Horan, et al.. (2019). From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis. The Oncologist. 25(3). 218–228. 7 indexed citations
13.
Peng, Rongxue, Rui Zhang, Li Zhou, et al.. (2019). External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants. Pathology & Oncology Research. 26(3). 1595–1603. 4 indexed citations
14.
Yang, Xin, et al.. (2019). Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer. BMC Cancer. 19(1). 465–465. 14 indexed citations
15.
Zhou, Li, Rongxue Peng, Rui Zhang, & Jinming Li. (2018). The applications of CRISPR/Cas system in molecular detection. Journal of Cellular and Molecular Medicine. 22(12). 5807–5815. 58 indexed citations
16.
17.
Peng, Rongxue, Guigao Lin, Xin Yang, et al.. (2017). CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing. Journal of Molecular Diagnostics. 19(5). 766–775. 7 indexed citations
18.
Li, Yulong, Rui Zhang, Rongxue Peng, et al.. (2016). Reliability Assurance of Detection of EML4-ALK Rearrangement in Non–Small Cell Lung Cancer: The Results of Proficiency Testing in China. Journal of Thoracic Oncology. 11(6). 924–929. 7 indexed citations
19.
Wang, Guojing, Yu Sun, Kuo Zhang, et al.. (2015). External Quality Assessment of Molecular Detection of Ebola Virus in China. PLoS ONE. 10(7). e0132659–e0132659. 11 indexed citations
20.
Peng, Rongxue, Guigao Lin, & Jinming Li. (2015). Potential pitfalls of CRISPR/Cas9‐mediated genome editing. FEBS Journal. 283(7). 1218–1231. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinzhi Duan Breakdown of academic impact, for papers by Wensheng Zhang Breakdown of academic impact, for papers by Cynthia M. Megyola Breakdown of academic impact, for papers by Hannah Greenfeld Breakdown of academic impact, for papers by Justin Low Breakdown of academic impact, for papers by R Seipelt Breakdown of academic impact, for papers by Kieran O’Neill Breakdown of academic impact, for papers by Samantha Maragh Breakdown of academic impact, for papers by Xavier Gaume
Rankless by CCL
2026